Misty Dawn Shields (@drshieldsmd) 's Twitter Profile
Misty Dawn Shields

@drshieldsmd

Translational Thoracic Oncologist, #MDPhD, @TheShieldsLab studying #SCLC, Asst Prof, Indiana University, HHMI Med Into Grad Scholar, IASLC ILCF @SCLCSMASHERS

ID: 1859413411

calendar_today13-09-2013 03:50:44

1,1K Tweet

1,1K Followers

1,1K Following

IU Simon Comprehensive Cancer Center (@iucancercenter) 's Twitter Profile Photo

The annual ASCO Review at IU will be 8 a.m.-2 p.m. Saturday, July 12 at the Marriott Indianapolis Downtown. IU faculty members will provide analysis of the more clinically applicable presentations at this year's ASCO meeting. Learn more: ow.ly/R8v450W8AB1.

The annual ASCO Review at IU will be 8 a.m.-2 p.m. Saturday, July 12 at the Marriott Indianapolis Downtown. IU faculty members will provide analysis of the more clinically applicable presentations at this year's <a href="/ASCO/">ASCO</a> meeting. Learn more: ow.ly/R8v450W8AB1.
Misty Dawn Shields (@drshieldsmd) 's Twitter Profile Photo

Thank you Live Lung LiveLung for shedding light 💡 on such an important topic. The search for biomarkers in lung cancer, especially SCLC, is of utmost importance. How do we get the RIGHT therapy for the RIGHT patient to improve outcomes & maximize quality & quantity of life?

Misty Dawn Shields (@drshieldsmd) 's Twitter Profile Photo

Thank you to Live Lung LiveLung for highlighting the need to expand lung cancer screening criteria - to help capture ALL “at risk” individuals, while balancing the risks of potential harm or false positives. Raymond Osarogiagbon, MBBS, FACP Nasser Hanna Michael Gieske, M.D. Jeff Yang MD FACS ALCSI

Misty Dawn Shields (@drshieldsmd) 's Twitter Profile Photo

Thank you to Live Lung LiveLung to helping spread the word on how tissue biopsies can be sometimes limited due to crush artifact & how liquid biopsies may help improve care for patients diagnosed with #SCLC #clinicaltrials #genomics Mya Tran SmallCellSMASHERS

Misty Dawn Shields (@drshieldsmd) 's Twitter Profile Photo

Honored to be invited to join the IASLC Rare Tumors Committee! Thankful for the opportunity to contribute to this amazing committee and to help impact education, outreach, & research surrounding #SCLC. SmallCellSMASHERS LUNGevity Foundation #LCSM

Honored to be invited to join the <a href="/IASLC/">IASLC</a> Rare Tumors Committee! 

Thankful for the opportunity to contribute to this amazing committee and to help impact education, outreach, &amp; research surrounding #SCLC. 

<a href="/SclcSMASHERS/">SmallCellSMASHERS</a> <a href="/LUNGevity/">LUNGevity Foundation</a> #LCSM
Misty Dawn Shields (@drshieldsmd) 's Twitter Profile Photo

Thank you to our excellent expert thoracic oncologists IU Simon Comprehensive Cancer Center for an amazing lung cancer OncLive.com #StateoftheScienceSummit tonight! We are grateful to all the attendees, OncLive.com & our sponsors who made tonight’s event fabulous! Let’s go Indiana Pacers! 🏀 Julian Marin

Thank you to our excellent expert thoracic oncologists <a href="/IUCancerCenter/">IU Simon Comprehensive Cancer Center</a> for an amazing lung cancer <a href="/OncLive/">OncLive.com</a> #StateoftheScienceSummit tonight!

We are grateful to all the attendees, <a href="/OncLive/">OncLive.com</a> &amp; our sponsors who made tonight’s event fabulous!

Let’s go <a href="/Pacers/">Indiana Pacers</a>! 🏀 

<a href="/jmarinacevedo/">Julian Marin</a>
Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

Overview of #SCLC at #CIOT25 from Sanjay Popat - chemo + atezo/durva is our 1L approach for ES SCLC. IMforte shows that maintenance lurbinectedin + atezolizumab improves OS and becomes our new standard of care, for now. Tarlatamab our new 2L SOC, will it move to maintenance?

Overview of #SCLC at #CIOT25 from <a href="/DrSanjayPopat/">Sanjay Popat</a> - chemo + atezo/durva is our 1L approach for ES SCLC. IMforte shows that maintenance lurbinectedin + atezolizumab improves OS and becomes our new standard of care, for now. Tarlatamab our new 2L SOC, will it move to maintenance?
Giannis Mountzios (@g_mountzios) 's Twitter Profile Photo

3 weeks after ASCO25, let’s digest the data from the landmark DeLLphi-304 trial published in NEJM that changed the >30 years SoC in recurrent #SCLC from immunobiology and clinical standpoints: 🧵 1/15 #some #LCSM @ASCO IASLC ESMO - Eur. Oncology ETOP IBCSG Partners Foundation EORTC SmallCellSMASHERS

3 weeks after <a href="/ASCO/">ASCO</a>25, let’s digest the data from the landmark DeLLphi-304 trial  published in <a href="/NEJM/">NEJM</a> that changed the &gt;30 years SoC in recurrent #SCLC from immunobiology and clinical standpoints:

🧵 1/15

#some #LCSM @ASCO  <a href="/IASLC/">IASLC</a>  <a href="/myESMO/">ESMO - Eur. Oncology</a> <a href="/etop_ibcsg/">ETOP IBCSG Partners Foundation</a>  <a href="/EORTC/">EORTC</a>  <a href="/SclcSMASHERS/">SmallCellSMASHERS</a>
Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

International retrospective report on #EGFR NSCLC transformed to #SCLC now ESMO Open, led by Dr. Chiara CATANIA. An area of significant unmet need - would like to see prospective studies here and I do think it is feasible. esmoopen.com/article/S2059-…

Misty Dawn Shields (@drshieldsmd) 's Twitter Profile Photo

Y’all. I have the BEST lab. 🥼 “On Wednesdays, we wear pink.” Surprise, surprise. My lab surprised me today for my upcoming 40th (sigh) birthday with a party, fabulous cake 🎂, donuts 🍩 & wearing my favorite color! 💕 The Shields Lab at IU Simon Comprehensive Cancer Center is simply amazing!🤩

Y’all. I have the BEST lab. 🥼 

“On Wednesdays, we wear pink.”

Surprise, surprise. 

My lab surprised me today for my upcoming 40th (sigh) birthday with a party, fabulous cake 🎂, donuts 🍩 &amp; wearing my favorite color! 💕

<a href="/TheShieldsLab/">The Shields Lab</a> at <a href="/IUCancerCenter/">IU Simon Comprehensive Cancer Center</a> is simply amazing!🤩